Breakdown of the blood-cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus: Post-exposure treatment with monoclonal antibody promotes recovery☆
References (18)
- et al.
Rejection of allogeneic tumor cells growing in mouse cerebrospinal fluid—Functional analysis of the inflammatory process
J. Neuroimmunol.
(1981) - et al.
The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay—An analysis of the interaction between hybridoma proteins and influenza virus
Mol. Immunol.
(1979) - et al.
Molecular biology and chemistry of the alternative pathway of complement
Adv. Immunol.
(1980) - et al.
Antibody-mediated destruction of virus-infected cells
Adv. Immunol.
(1980) - et al.
Influenza encephalitis in mice—A histopathological and electron microscopic study
Arch. Ges. Virusforsch.
(1971) Quantitative studies of the inflammatory process in fatal meningoencephalitis
Amer. J. Path.
(1973)- et al.
Specificity of virus-immune effector T cells for H-2K or H-2D comparable interactions—Implications for H-antigen diversity
Transplant. Rev.
(1976) - et al.
An improved assay for the infectivity of influenza viruses
J. Hyg. (Camb.)
(1958) - et al.
The analysis of the monoclonal immune response to influenza virus, Part 1 (Production of monoclonal antiviral antibodies in vitro)
Europ. J. Immunol.
(1975)
There are more references available in the full text version of this article.
Cited by (20)
Antibody-mediated clearance of viruses from the mammalian central nervous system
1993, Trends in MicrobiologyInflammation in virus infections
1993, Seminars in VirologyA role for γ/δ T cells in the primary immune response to influenza virus
1990, Research in ImmunologyThe application of monoclonal antibodies in the study of viruses
1984, Advances in Virus Research
- ☆
These experiments were funded by grants from the National Multiple Sclerosis Society and the National Institutes of Health (NS 11036, AI 13989 and AI 14162).
Copyright © 1981 Published by Elsevier B.V.